What can we learn from Biogen's decision to halt sales of aducanumab?
Richard G. Stefanacci, DO, MGH, MBA, AGSF, CMD
Advertisement
Articles by Richard G. Stefanacci, DO, MGH, MBA, AGSF, CMD
Advertisement
Latest Updated Articles
Current Implications for the Managed Care of DementiaPublished: December 1st 2007 | Updated:
- The Costs of Alzheimer's Disease and the Value of Effective Therapies
Published: November 11th 2011 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Government Shutdown Could Disrupt Health Care Access
2
Most Medicare Beneficiaries Find Plan Shopping Confusing, Survey Finds
3
Maternal, Child Mortality Higher in the US Compared With Majority of High-Income Countries
4
Lurbinectedin Combo Approved by FDA for Extensive-Stage Small Cell Lung Cancer
5
